StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Gilead Sciences (GILD) PT Raised to $89 at RBC Capital
February 5, 2019 6:46 AM
RBC Capital analyst Brian Abrahams raised the price target on Gilead Sciences (NASDAQ: GILD) to $89.00 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS View
Analyst PT Change
Next Articles
Gilead Sciences (GILD) PT Lowered to $90 at Raymond James
February 5, 2019 9:00 AM
Gilead Sciences (GILD) PT Lowered to $100 at Citi
February 5, 2019 6:59 AM
Gilead Sciences (GILD) Raises Quarterly Dividend 10.5% to $0.63; 3.6% Yield
February 4, 2019 4:03 PM
Gilead Sciences (GILD) Misses Q4 EPS by 27c, Offers FY Guidance
February 4, 2019 4:02 PM
Gilead Sciences Announces 11 Percent Increase in First Quarter 2019 Dividend
February 4, 2019 4:02 PM
Gilead Sciences Announces Fourth Quarter and Full Year 2018 Financial Results
February 4, 2019 4:01 PM
